Immune control strategies for vaccinia virus-related laboratory-acquired infections.

Author: Qiang WEI ¹ ; Meng Nan JIANG ¹ ; Jun HAN ² ; Zi Jun WANG ¹
Author Information

1. Office of Laboratory Management, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
2. National Institute for Virus Disease Control and Prevention, China CDC Beijing 102206, China.
Publication Type:Journal Article
MeSH: Contraindications; Humans; Smallpox Vaccine; adverse effects; Vaccination; standards; Vaccinia; immunology; prevention & control; Vaccinia virus; immunology
From: Biomedical and Environmental Sciences 2014;27(2):142-146
CountryChina
Language:English
Abstract: While presenting biological characteristics of vaccinia virus and laboratory-acquired infections during related research processes, this paper focuses on benefits and risks of vaccinia virus immunization in relation to laboratory-acquired infections, describes characteristics and the adaptation of vaccinia virus vaccine, analyses the role vaccinia virus immunization plays in the prevention and control of laboratory-acquired infections, and finally proposes solutions and countermeasures to further promote and implement immune control strategies. The problem related to immune strategy and laboratory- acquired infections which is being raised, analyzed and explored plays an active and instructive role in vaccinia virus related researches and laboratory- acquired infections, and also helps to recommend and develop relevant immune strategy for future vaccine control of such infections.